Alignment Healthcare, Inc. (ALHC)
| Market Cap | 1.52B -55.6% |
| Revenue (ttm) | 4.94B +35.9% |
| Net Income | 28.92M |
| EPS | 0.14 |
| Shares Out | 209.27M |
| PE Ratio | 51.62 |
| Forward PE | 19.27 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,140,690 |
| Open | 7.45 |
| Previous Close | 7.56 |
| Day's Range | 7.15 - 7.62 |
| 52-Week Range | 6.01 - 25.12 |
| Beta | 1.04 |
| Analysts | Buy |
| Price Target | 10.79 (+48.62%) |
| Earnings Date | Oct 29, 2026 |
About ALHC
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.
Financial Performance
In 2025, Alignment Healthcare's revenue was $3.95 billion, an increase of 46.06% compared to the previous year's $2.70 billion. Losses were -$724,000, -99.43% less than in 2024.
Financial StatementsAnalyst Summary
According to 15 analysts, the average rating for ALHC stock is "Buy." The 12-month stock price target is $10.79, which is an increase of 48.62% from the latest price.
News
ALHC Investigation Reminder: Alignment Healthcare Investors Notified of Securities Fraud Investigation – Contact BFA Law
NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Alignment Healthcare, Inc. (NASDAQ:ALHC) for potential securities fr...
ALHC Investigation Reminder: Alignment Healthcare Inflated EBITDA Triggers Securities Fraud Investigation for Investors – Contact BFA Law if You Lost Money
BFA Law is investigating whether Alignment Healthcare, Inc. committed securities fraud relating to allegations that the company and its senior executives artificially inflated adjusted EBITDA to boost...
ALHC Shareholder Notice: Alignment Healthcare Under Investigation for Potential Securities Fraud over Alleged Misrepresentations to Investors
BFA Law is investigating whether Alignment Healthcare, Inc. committed securities fraud relating to allegations that the company and its senior executives artificially inflated adjusted EBITDA to boost...
Alignment Healthcare price target lowered to $10 from $12 at TD Cowen
TD Cowen analyst Gary Taylor lowered the firm’s price target on Alignment Healthcare (ALHC) to $10 from $12 and keeps a Buy rating on the shares. The firm updated its…
ALHC Legal Notice: Alignment Healthcare Investors are Notified to Contact BFA Law About the Ongoing Securities Fraud Investigation
NEW YORK--(BUSINESS WIRE)---- $ALHC #ALHC--Alignment Healthcare Investors are Notified to Contact BFA Law About the Ongoing Securities Fraud Investigation.
Alignment Healthcare Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alignment Healthcare, Inc. - ALHC
NEW ORLEANS, Oct. 30, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
Alignment Healthcare (NASDAQ: ALHC) Increasingly Scrutinized Over H3815 Cut Points And CMS Bonus Eligibility - HBSS
SAN FRANCISCO, Oct. 30, 2026 /PRNewswire/ -- On October 9, 2026, investors Alignment Healthcare, Inc. (NASDAQ: ALHC) saw the price of their shares slide another 13% to close at $7.55, reaching a 52 we...
Alignment Healthcare price target lowered to $8 from $10 at JPMorgan
JPMorgan analyst John Stansel lowered the firm’s price target on Alignment Healthcare (ALHC) to $8 from $10 and keeps an Overweight rating on the shares.
Alignment Healthcare price target lowered to $8 from $9 at UBS
UBS lowered the firm’s price target on Alignment Healthcare (ALHC) to $8 from $9 and keeps a Neutral rating on the shares.
Alignment Healthcare price target lowered to $10 from $11 at Stephens
Stephens analyst Raj Kumar lowered the firm’s price target on Alignment Healthcare (ALHC) to $10 from $11 and keeps an Overweight rating on the shares as the firm updated estimates…
ALHC Investigation Reminder: Alignment Healthcare Under Investigation for Potential Securities Fraud Over Inflated EBITDA – Contact BFA Law if You Lost Money
NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Alignment Healthcare, Inc. (NASDAQ:ALHC) for potential securities fr...
Alignment Healthcare price target lowered to $9 from $10 at Barclays
Barclays analyst Andrew Mok lowered the firm’s price target on Alignment Healthcare (ALHC) to $9 from $10 and keeps an Equal Weight rating on the shares.
Alignment Healthcare downgraded to Sector Weight from Overweight at KeyBanc
KeyBanc analyst Matthew Gillmor downgraded Alignment Healthcare (ALHC) to Sector Weight from Overweight without a price target The company’s EBITDA baseline for 2027 is “somewhat unclear” given the hi...
Alignment Healthcare Earnings Call Transcript: Q3 2026
Q3 revenue grew 37% YoY, but elevated claims costs led to lower FY26 guidance. Management expects at least 20% growth in 2027 while pursuing claims, clinical and Stars improvements.
Alignment Healthcare Earnings release: Q3 2026
Alignment Healthcare released its Q3 2026 earnings on October 29, 2026, summarizing the period's financial results.
Alignment Healthcare Quarterly report: Q3 2026
Alignment Healthcare has published its Q3 2026 quarterly earnings report on October 29, 2026.
Alignment Healthcare raises FY26 revenue view to $5.25B from$5.2B-$5.23B
Consensus $5.22B. Sees FY26 adjusted EBITDA $100M. The company said, “Full-year health plan membership and revenue guidance was raised to reflect continued sales momentum, while adjusted gross profit ...
Alignment Healthcare reports Q3 EPS (4c), consensus 4c
Reports Q3 revenue $1.36B, consensus $1.31B. “Our third-quarter membership and revenue growth demonstrate continued demand for Alignment’s products and services, while medical trends ran higher than e...
Alignment Healthcare sees Q4 revenue $1.32B, consensus $1.33B
Sees Q4 adjusted EBITDA loss $28M.
Alignment Healthcare Reports Third Quarter 2026 Results, Updates Full-Year Outlook
ORANGE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its third quarter ended Sept. 30, 2026.
Alignment Healthcare initiated with a Hold at Needham
Needham analyst Matthew Shea initiated coverage of Alignment Healthcare (ALHC) with a Hold rating and no price target The firm believes Alignment is well positioned to gain share in Medicare…
ALHC Investor Investigation: Alignment Healthcare Investors Are Alerted to the Securities Fraud Investigation after Inflated EBITDA Leads to 16% Stock Drop
BFA Law is investigating whether Alignment Healthcare, Inc. committed securities fraud relating to allegations that the company and its senior executives artificially inflated adjusted EBITDA to boost...
$ALHC Stock Losses: BFA Law Reminds Alignment Healthcare Investors with Losses of the Ongoing Securities Fraud Investigation into Potential Inflated EBITDA Misrepresentations
BFA Law Reminds Alignment Healthcare Investors with Losses of the Ongoing Securities Fraud Investigation into Potential Inflated EBITDA Misrepresentations
ALHC Investigation News: Alignment Healthcare Investors are Notified of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money
NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Alignment Healthcare, Inc. (NASDAQ:ALHC) for potential securities fr...
Alignment Health Adds New Medicare Advantage Plan in Pima County, Increasing Access and Choice for Arizona Seniors
New plan strengthens Alignment's Arizona portfolio available to nearly 1.1 million Medicare beneficiaries across Maricopa, Pima and Santa Cruz counties New plan strengthens Alignment's Arizona portfol...